Atle Fund Management AB Has $12.64 Million Stake in Intuitive Surgical, Inc. $ISRG

Atle Fund Management AB lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.3% during the fourth quarter, HoldingsChannel reports. The firm owned 22,322 shares of the medical equipment provider’s stock after acquiring an additional 2,615 shares during the quarter. Intuitive Surgical comprises 4.0% of Atle Fund Management AB’s holdings, making the stock its 6th largest holding. Atle Fund Management AB’s holdings in Intuitive Surgical were worth $12,642,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Newbridge Financial Services Group Inc. lifted its holdings in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares in the last quarter. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Laurel Wealth Advisors LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $31,000. Finally, Turning Point Benefit Group Inc. raised its position in Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 50 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $446.95, for a total value of $178,780.00. Following the transaction, the executive vice president owned 6,120 shares in the company, valued at approximately $2,735,334. This represents a 6.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 645 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the transaction, the senior vice president owned 1,613 shares in the company, valued at approximately $782,321.13. The trade was a 28.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 5,647 shares of company stock worth $2,760,359 over the last quarter. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.4%

Shares of ISRG stock opened at $441.58 on Wednesday. The stock has a market cap of $156.39 billion, a price-to-earnings ratio of 53.52, a PEG ratio of 3.51 and a beta of 1.51. The stock has a 50-day moving average of $461.52 and a 200-day moving average of $512.36. Intuitive Surgical, Inc. has a 1-year low of $417.74 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the prior year, the company earned $1.81 EPS. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent analyst reports. Raymond James Financial lowered their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler lowered their price target on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Mizuho set a $525.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a report on Monday, April 13th. Robert W. Baird upped their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Finally, The Goldman Sachs Group upped their target price on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $579.33.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.